跳至主要内容
临床试验/JPRN-UMIN000023802
JPRN-UMIN000023802已完成未知

A Phase II Study of biweekly Carboplatin, nab-paclitaxel, and concurrent Thoracic radiation therapy for Patients with local advanced Non-small cell Lung Cancer - A Phase II Study of biweekly Carboplatin, nab-paclitaxel, and concurrent Thoracic radiation therapy for Patients with local advanced Non-small cell Lung Cancer

Hirosaki University0 个研究点目标入组 28 人开始时间: 2016年8月28日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
28

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) T3N1 2) Superior vena cava syndrome. 3) Lymph node metastases of opposite side hilum, malignant pleuritis, malignant pericarditis, lymphangitis. 4) With active double cancer. 5) Active infection. 6) Other serious disease condition (idiopathic pulmonary fibrosis, interstitial lung disease, renal failure, liver failure, Cerebral Vascular Disorder, unstable angina, cardiac infarction, Myocardial Infarction, poorly controlled diabetes mellitus,etc). 7) Grade2< peripheral neuropathy. 8) Severe drug allergy. 9) Pregnancy or lactation. 10) Patient whose participation in the trial is judged to be inappropriate by the attending doctor.

研究者

相似试验